Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Immunovaccine and Oncothyreon to jointly develop cancer vaccine

July 1, 2010

Futura Medical and GSK join to develop TPR-100 for topical pain relief

July 1, 2010

Aestus to develop Astellas' FK-614 as ATx-08-001 for neuropathic pain

June 30, 2010

Upsher-Smith acquires Ikano's ITI-111 for management of acute repetitive seizures

June 30, 2010

Aeterna Zentaris and Almac to develop companion diagnostic for AEZS-108 cancer therapy

June 30, 2010

MorphoSys and Xencor collaborate on mAb for B-cell malignancies

June 29, 2010

AstraZeneca and MMV join to identify antimalaria candidates

June 29, 2010

Sanofi-aventis and Metabolex enter into licensing agreement for novel antidiabetic

June 28, 2010

Santaris and miRagen develop microRNA-targeted cardiovascular medicines

June 28, 2010

Amorfix and QED to co-develop high-affinity monoclonal antibodies for cancer

June 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.